ArthroCAD completed Series A round of financing to secure funds for its total hip arthroplasty product development. Edgar Jannotta, a former GTCR managing principal, is one of the investors in the orthopedic device company.
All parties are looking to ArthroCAD to develop safer, more accurate implants for THA.
More Articles on Devices:
Zimmer to Close Austin Device Plant in July
MAKO Surgical Gives $265k Research Grant to Rebound Orthopedics & Neurosurgery
AxioMed Spine Collects $3.6M in Device Development Funding
All parties are looking to ArthroCAD to develop safer, more accurate implants for THA.
More Articles on Devices:
Zimmer to Close Austin Device Plant in July
MAKO Surgical Gives $265k Research Grant to Rebound Orthopedics & Neurosurgery
AxioMed Spine Collects $3.6M in Device Development Funding